bioAffinity’s AI Lung-Cancer Stock Jumped Nearly 48% After a Reverse Split. What Would Have to Go Right?
Last Update:
5 9 月, 2026
Our site uses cookies. By using this site, you agree to the Privacy Policy and Terms of Use.